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Dietary fatty acids and age-related macular degeneration 
Abstract 
Age-related macular degeneration (AMD) is a leading cause of vision loss and blindness among older 
people. It is important to identify modifiable risk factors which could prevent or slow the progression of 
this chronic disease. Dietary fatty acid intakes have been investigated in epidemiological studies as it is 
plausible that individual lipids have properties which modulate cellular damage in the eye. This paper 
reviews epidemiological studies investigating links between fatty acids and AMD. Mixed evidence has 
related the sub-types of saturated and monounsaturated fatty acids to AMD, but nearly all epidemiological 
studies have demonstrated some level of AMD protection from omega-3 polyunsaturated fatty acids 
(particularly long-chain fatty acids) and fish, with a tendency for a corresponding dampening effect with 
increased dietary omega-6 polyunsaturated fatty acids. 
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fatty acids (10). Statistical models for fatty acid sub-types were
adjusted for known confounders of AMD but not simultaneously for
other sub-types of fatty acids. As in the previous study, a higher
frequency of fish consumption in the presence of low linoleic acid
intake reduced the risk of AMD progression (p for trend 0.045). In a
study by Cho et al of risk of AMD and fatty acid sub-types among
567 participants of the Nurses Health Study and the Health
Professionals Follow-up Study, there was no association between
incident late AMD and increasing dietary intakes of vegetable or
unsaturated fats (11). 
The Blue Mountains Eye Study examined the association between
dietary fat and fatty acid components and the 5-year incidence of
AMD (12). This is a population-based cohort study of vision and
common eye diseases in non-institutionalised residents, 49 years or
older, living in the Blue Mountains region, west of Sydney, Australia.
Dietary data were collected from 2895 people at baseline using a
validated food frequency questionnaire. Incidence of early and late
AMD was assessed after a mean follow-up of 5.1 years. Participants
with the highest verses the lowest quintile of omega-3 PUFA had a
lower risk of AMD (OR 0.41, 95 percent CI 0.22-0.75). A 40%
reduction of incident early AMD was associated with f ish
consumption of at least once a week (OR 0.58, 95 percent CI 0.4-
0.9), and fish consumption of at least 3 times a weeks reduced the
incidence of late AMD by 75 percent (OR 0.25, 95 percent CI 0.06,
1.0). There was no significant association between AMD and
margarine or butter consumption. There was a non-significant
protective effect of nuts consumed at least weekly. Although not
statistically significant, the trend for long-chain omega-3 PUFA also
suggested protection. Low intakes of the essential fatty acid 
α-linolenic acid, an omega-3 PUFA, were associated with increased
risk, suggesting it too may be protective for AMD. This study
confirmed an earlier cross-sectional report in the same cohort of
Age-related macular degeneration (AMD) is the most frequent cause
of severe vision loss and blindness in elderly people (1-3). Although
new treatments targeting vascular endothelial growth factor (VEGF)
have revolutionized the management of this condition, this therapy is
not possible for many cases, requires regular injections into the eye
and is costly. Identifying risk factors that could be targeted in
preventive strategies therefore has the potential to reduce the
burden of macular degeneration in our ageing populations.
Diet has already been identified as an important modifiable risk
factor and the management of AMD has been influenced by
evidence from the Age-Related Eye Disease Study (AREDS) which
demonstrated that a high dose zinc and antioxidant vitamin
supplement (vi tamin C, E and beta-carotene) slowed AMD
progression by around 25 percent in relatively advanced AMD
stages (4). Dietary fatty acids are another important potential dietary
factor worthy of investigation. Dietary fatty acid intake may be
related to AMD development through its effect on atherosclerosis
and their presence in ret inal and macular cel ls. Omega-3
polyunaturated fatty acids (PUFA), particularly docosahexaenoic
acid (DHA), constitute a high proportion of the human retina and
macular composition, and may be important in cell membrane
maintenance and retinal repair following oxidative stress. They may
also protect against retinal inflammation (5-6). It is believed that
AMD shares some aspects of the pathogenesis as cardiovascular
disease (7-8). Several recent reports have examined possible
associations between dietary fat and progression of macular
degeneration. Earlier epidemiological studies suggested dietary
intake of fat and al l  i ts subtypes, including vegetable and
unsaturated fats, could increase the risk of progression, though this
seemed at odds with the known relationship of fatty acids and
cardiovascular disease. 
In a case-control study of older people attending ophthalmology
centres in the US (n=349 cases), people consuming the highest
quintile of monounsaturated fat and polyunsaturated fat had a higher
risk of AMD compared to those in the lowest quintile (OR 1.71 (95
percent CI 1.0-2.94; 1.86 (95 percent CI 1.1-3.1, respectively), after
adjusting for other known risk factors of AMD (9). This same study
found that people who consumed higher omega-3 fatty acids
(eicosapentoic acid (EPA) and DHA) and higher frequency of fish in
the presence of a low linoleic PUFA intake (an omega-6 PUFA) had
a reduced risk for ARM (p for trend 0.05), but this was not the case
in the presence of a higher linoleic fatty acid intake. In another study
of a select group of older people attending an eye clinic for early
AMD (n=261), a higher total fat intake (p for trend p=0.01) and
higher vegetable fat intake (p for trend p=0.003) was associated with
an increased risk of ARM progression, as did other sub-types of fat;
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ABSTRACT: Age-related macular degeneration (AMD) is a leading cause of vision loss and blindness among older people. It is
important to identify modifiable risk factors which could prevent or slow the progression of this chronic disease. Dietary fatty acid intakes
have been investigated in epidemiological studies as it is plausible that individual lipids have properties which modulate cellular damage
in the eye. This paper reviews epidemiological studies investigating links between fatty acids and AMD. Mixed evidence has related the
sub-types of saturated and monounsaturated fatty acids to AMD, but nearly all epidemiological studies have demonstrated some level
of AMD protection from omega-3 polyunsaturated fatty acids (particularly long-chain fatty acids) and fish, with a tendency for a
corresponding dampening effect with increased dietary omega-6 polyunsaturated fatty acids.
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50% protective effect of fish consumed more than once per week
compared to less than once per month (13). In a more recent study
reported by the AREDS group in which participants with varying
levels of AMD severity are compared to a control group, people who
consumed higher intake of total long-chain omega-3 PUFA had a
lower risk for neovascular AMD (OR 0.6, 95 percent CI 0.4-0.9), with
similar finding for DHA and fish intake. Arachidonic acid, an omega-6
PUFA, increased the risk of neovascular AMD by about 50 percent
(OR 1.5, 95 percent CI 1.0-2.3) (14). There were no other
statistically significant associations with other sub-types of fatty
acids and AMD. 
CONCLUSIONS
Overall, findings from a range of epidemiological studies support the
hypothesis that an increased dietary intake of long-chain omega-3
polyunsaturated fatty acids and regular fish in the diet protects
against the development and progression of AMD. A plausible
mechanism is that long chain omega-3 PUFA promotes healthy
ocular tissue by regulating inflammatory and immune responses in
the retina, thereby reducing the risk of AMD. It may be that the
presence of higher omega-6 fatty acids (mainly linoleic fatty acid and
possibly arachidonic fatty acid) dampens the effect of omega-3
PUFA. Evidence for an association between other fatty acid sub-
types (monounsaturated and saturated fatty acids) and AMD,
however. has been less consistent. In addition to the observational
epidemiological studies, it would be valuable to have information
from clinical trials about the effect of dietary interventions or
supplements with long chain omega-3 PUFA and AMD. Such a study
is planned with an extension of the AREDS trial, testing the role of
omega-3 PUFA supplementation on AMD progression, though
findings will not be available for many years (15).
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